NASDAQ:ALGN - Align Technology Stock Price, Price Target & More

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) released its quarterly earnings data on Wednesday, April, 25th. The medical equipment provider reported $1.17 EPS for the quarter, beating analysts' consensus estimates of $0.98 by $0.19. The medical equipment provider had revenue of $436.92 million for the quarter, compared to analysts' expectations of $408.27 million. Align Technology had a return on equity of 30.36% and a net margin of 16.12%. The firm's quarterly revenue was up 40.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.59 earnings per share. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Align Technology.

Align Technology updated its second quarter earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $1.02-1.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.03. The company issued revenue guidance of $460-470 million, compared to the consensus revenue estimate of $452.20 million.

15 brokerages have issued 12 month price targets for Align Technology's shares. Their predictions range from $210.00 to $430.00. On average, they expect Align Technology's stock price to reach $336.6667 in the next twelve months. This suggests that the stock has a possible downside of 10.3%. View Analyst Ratings for Align Technology.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Steris (STE), Inogen (INGN), MSA Safety (MSA), Halyard Health (HYH), Wright Medical Group (WMGI), CONSORT Med PLC/S (CSRMY), Invacare (IVC), Sientra (SIEN) and RTI Surgical (RTIX).

News articles about ALGN stock have trended somewhat positive this week, Accern reports. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Align Technology earned a daily sentiment score of 0.04 on Accern's scale. They also assigned media coverage about the medical equipment provider an impact score of 46.93 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Align Technology's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Rathbone Brothers plc (0.27%), Bank of Montreal Can (0.19%), Scout Investments Inc. (0.15%), Fred Alger Management Inc. (0.14%), Fisher Asset Management LLC (0.08%) and Gateway Investment Advisers LLC (0.07%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Rathbone Brothers plc, Fisher Asset Management LLC, Hartford Investment Management Co., Sit Investment Associates Inc., Gateway Investment Advisers LLC, Conestoga Capital Advisors LLC and Municipal Employees Retirement System of Michigan. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler. View Insider Buying and Selling for Align Technology.

ALGN stock was bought by a variety of institutional investors in the last quarter, including Fred Alger Management Inc., Scout Investments Inc., Bank of Montreal Can, Pendal Group Ltd, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Westpac Banking Corp, Jag Capital Management LLC and Fox Run Management L.L.C.. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $375.38.

Align Technology has a market capitalization of $29.68 billion and generates $1.47 billion in revenue each year. The medical equipment provider earns $231.41 million in net income (profit) each year or $3.89 on an earnings per share basis. Align Technology employs 8,715 workers across the globe.

Align Technology's mailing address is 2560 ORCHARD PARKWAY, SAN JOSE CA, 95131. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]